Wasat Mansoor

机构：Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, The Christie Hospital, The Christie NHS Foundation Trust · ORCID：0000-0002-1477-4934

发表论文 168 篇 · 总被引 11303 次 · h-index 33

代表论文

• Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer (2025 · New England Journal of Medicine · 被引 96)
• First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study (2024 · Journal of Clinical Oncology · 被引 58)
• Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study (2025 · Journal of Clinical Oncology · 被引 37)
• Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial (2023 · Journal for ImmunoTherapy of Cancer · 被引 28)
• Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter (2022 · Endocrine · 被引 27)
• NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma (2023 · EClinicalMedicine · 被引 24)